SOUTH SAN FRANCISCO, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc., a leader in extracellular protein degradation, today announced that Aetna Wun Trombley, Ph.D., President and...
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc., a leader in extracellular protein degradation, today announced that founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry. The Royal Swedish Academy of Sciences recognized Dr. Bertozzi for her pioneering work in bioorthogonal chemistry that enabled researchers to interrogate molecules in living systems with click chemistry. The Prize was also awarded to Morten Meldal, professor at University of Copenhagen, and K. Barry Sharpless, professor at Scripps Research, for laying the foundation for a functional form of click chemistry in which molecular building blocks snap together quickly and efficiently.
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc., a leader in extracellular protein degradation, today announced the recent appointment of Steve Staben, Ph.D.,...
Lycia Therapeutics has grabbed a $70 million series B for its next-generation degradation approach to zero in on the untapped extracellular proteome.
Lilly doubles down on protein degradation with $35M Lycia deal